Patrícia R Faustino1,2, Gonçalo S Duarte1,2, Inês Chendo3,4,5, Ana Castro Caldas2,5,6, Sofia Reimão1,2,7, Ricardo M Fernandes1,2, José Vale7,8, Michele Tinazzi9, Kailash Bhatia10, Joaquim J Ferreira1,2,5. 1. Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. 2. Instituto de Medicina Molecular, Lisbon, Portugal. 3. Psychiatry Department, Department of Neurosciences, Hospital de Santa Maria, Lisbon, Portugal. 4. Clínica Universitária de Psiquiatria, Faculty of Medicine, University of Lisbon, Lisbon, Portugal. 5. CNS-Campus Neurológico Senior, Torres Vedras, Portugal. 6. Neurology Service, Department of Neurosciences, Hospital de Santa Maria, Lisbon, Portugal. 7. Neurological Imaging Department, Hospital de Santa Maria, Lisbon, Portugal. 8. Neurology Department, Hospital de Beatriz Angelo, Loures, Portugal. 9. Department of Neuroscience, Biomedicine and Movement Sciences, Università di Verona, Verona, Italy. 10. Institute of Neurology, University College London, London, United Kingdom.
Abstract
Importance: Parkinson disease (PD) manifests by motor and nonmotor symptoms, which may be preceded by mood disorders by more than a decade. Bipolar disorder (BD) is characterized by cyclic episodes of depression and mania. It is also suggested that dopamine might be relevant in the pathophysiology of BD. Objective: To assess the association of BD with a later diagnosis of idiopathic PD. Data Sources: An electronic literature search was performed of Cochrane Controlled Register of Trials, MEDLINE, Embase, and PsycINFO from database inception to May 2019 using the terms Parkinson disease, bipolar disorder, and mania, with no constraints applied. Study Selection: Studies that reported data on the likelihood of developing PD in BD vs non-BD populations were included. Two review authors independently conducted the study selection. Data Extraction and Synthesis: Two review authors independently extracted study data. Data were pooled using a random-effects model, results were abstracted as odds ratios and 95% CIs, and heterogeneity was reported as I2. Main Outcome and Measures: Odds ratios of PD. Results: Seven studies were eligible for inclusion and included 4 374 211 participants overall. A previous diagnosis of BD increased the likelihood of a subsequent diagnosis of idiopathic PD (odds ratio, 3.35; 95% CI, 2.00-5.60; I2 = 92%). A sensitivity analysis was performed by removing the studies that had a high risk of bias and also showed an increased risk of PD in people with BD (odds ratio, 3.21; 95% CI, 1.89-5.45; I2 = 94%). Preplanned subgroup analyses according to study design and diagnostic certainty failed to show a significant effect. Conclusions and Relevance: This review suggests that patients with BD have a significantly increased risk of developing PD compared with the general population. Subgroup analyses suggested a possible overestimation in the magnitude of the associations. These findings highlight the probability that BD may be associated with a later development of PD and the importance of the differential diagnosis of parkinsonism features in people with BD.
Importance: Parkinson disease (PD) manifests by motor and nonmotor symptoms, which may be preceded by mood disorders by more than a decade. Bipolar disorder (BD) is characterized by cyclic episodes of depression and mania. It is also suggested that dopamine might be relevant in the pathophysiology of BD. Objective: To assess the association of BD with a later diagnosis of idiopathic PD. Data Sources: An electronic literature search was performed of Cochrane Controlled Register of Trials, MEDLINE, Embase, and PsycINFO from database inception to May 2019 using the terms Parkinson disease, bipolar disorder, and mania, with no constraints applied. Study Selection: Studies that reported data on the likelihood of developing PD in BD vs non-BD populations were included. Two review authors independently conducted the study selection. Data Extraction and Synthesis: Two review authors independently extracted study data. Data were pooled using a random-effects model, results were abstracted as odds ratios and 95% CIs, and heterogeneity was reported as I2. Main Outcome and Measures: Odds ratios of PD. Results: Seven studies were eligible for inclusion and included 4 374 211 participants overall. A previous diagnosis of BD increased the likelihood of a subsequent diagnosis of idiopathic PD (odds ratio, 3.35; 95% CI, 2.00-5.60; I2 = 92%). A sensitivity analysis was performed by removing the studies that had a high risk of bias and also showed an increased risk of PD in people with BD (odds ratio, 3.21; 95% CI, 1.89-5.45; I2 = 94%). Preplanned subgroup analyses according to study design and diagnostic certainty failed to show a significant effect. Conclusions and Relevance: This review suggests that patients with BD have a significantly increased risk of developing PD compared with the general population. Subgroup analyses suggested a possible overestimation in the magnitude of the associations. These findings highlight the probability that BD may be associated with a later development of PD and the importance of the differential diagnosis of parkinsonism features in people with BD.
Authors: Eduard Vieta; Michael Berk; Thomas G Schulze; André F Carvalho; Trisha Suppes; Joseph R Calabrese; Keming Gao; Kamilla W Miskowiak; Iria Grande Journal: Nat Rev Dis Primers Date: 2018-03-08 Impact factor: 52.329
Authors: Amy M Kilbourne; Jack R Cornelius; Xiaoyan Han; Harold A Pincus; Mujeeb Shad; Ihsan Salloum; Joseph Conigliaro; Gretchen L Haas Journal: Bipolar Disord Date: 2004-10 Impact factor: 6.744
Authors: Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag Journal: Ann Neurol Date: 2012-10-15 Impact factor: 10.422
Authors: William Yuan; Brett Beaulieu-Jones; Richard Krolewski; Nathan Palmer; Christine Veyrat-Follet; Francesca Frau; Caroline Cohen; Sylvie Bozzi; Meaghan Cogswell; Dinesh Kumar; Catherine Coulouvrat; Bruno Leroy; Tanya Z Fischer; S Pablo Sardi; Karen J Chandross; Lee L Rubin; Anne-Marie Wills; Isaac Kohane; Scott L Lipnick Journal: BMC Neurol Date: 2021-05-18 Impact factor: 2.474
Authors: Aoji Xie; Elizabeth Ensink; Peipei Li; Juozas Gordevičius; Lee L Marshall; Sonia George; John Andrew Pospisilik; Velma T E Aho; Madelyn C Houser; Pedro A B Pereira; Knut Rudi; Lars Paulin; Malú G Tansey; Petri Auvinen; Patrik Brundin; Lena Brundin; Viviane Labrie; Filip Scheperjans Journal: Mov Disord Date: 2022-06-20 Impact factor: 9.698
Authors: Marco Onofrj; Angelo Di Iorio; Claudia Carrarini; Mirella Russo; Raffaella Franciotti; Alberto J Espay; Laura S Boylan; John-Paul Taylor; Massimo Di Giannantonio; Giovanni Martinotti; Enza M Valente; Astrid Thomas; Laura Bonanni; Stefano Delli Pizzi; Fedele Dono; StefanoL Sensi Journal: Mov Disord Date: 2021-08-24 Impact factor: 9.698